Find the right patients and the right sites, faster
A community-weighted research network and oncology-specific AI pre-screening work together, so teams spend less time guessing which sites and patients are a fit, and more time activating them.
How OncoLens helps
Four ways teams stop guessing and start activating.
Access to the OncoLens Research Network
- Reach that goes where most oncology patients are treated
- 225+ cancer center locations, 90% community-based
- Spanning Phase 1 to 4 studies, CAR-T, RLT and specialized therapies
Feasibility-based connections, not a directory
- Outreach goes where there is a real chance of enrolling
- OncoLens matches centers and PIs on demonstrated fit for your protocol
- OncoLens makes the introduction directly
Oncology-focused AI pre-screening
- Built for the complexity of oncology, not adapted to it
- OncoLens reviews patient data against trial eligibility criteria
- A human in the loop confirms every match before contact
Analytics reported back to you
- Turnkey dashboards and personalized alerts
- Patients deemed medically eligible
- Declines, and the reasons for decline
What comes back to you
Every match is confirmed by a clinical team before it reaches you. On each trial you get who is medically eligible, whether they were randomized or declined, and the reason behind each.
Medically eligible
- Prior therapy
- Disease stage
- Performance status
- Biomarker status
- Social drivers of health
- Timeliness
Case studies
Finding the right patients and sites in practice.
Oncology-Focused AI/LLM To Find the Right Patients for Clinical Trials
Specialized AI and NLP streamline patient identification for oncology trials, including DLBCL and LUNGMAP studies, cutting manual chart-review time while improving match speed and precision.
Read the full case study →
A New Era in Trial Matching: Real-Time Oncology Data to Drive Enrollment
A Wisconsin-based IDN’s stalled prostate cancer trial went from zero enrollments to five new patients identified in the first review, with a first patient enrolled within one week.
Read the full case study →
Frequently asked questions
How does OncoLens identify oncology clinical trial sites?
Through the OncoLens Research Network: 225+ cancer center locations, roughly 90% community-based, spanning Phase 1 to 4 studies, CAR-T, RLT and specialized therapies, with feasibility-based connections and direct introductions to centers and principal investigators.
What does “feasibility-based” mean in site identification?
Centers and PIs are matched based on demonstrated fit for a specific protocol and patient population, rather than surfaced from a generic directory, so outreach goes to sites with a real chance of activating and enrolling.
How does the patient pre-screening work?
Oncology-focused AI reviews patient data against trial eligibility criteria and surfaces likely candidates through turnkey dashboards and personalized alerts, with a human in the loop confirming every match before contact.
What analytics come back from the pre-screening process?
Reporting on key trial stats, including the number of patients deemed medically eligible, the number declined, and the reasons for decline, giving visibility into where a trial gains or loses candidates.
Is this only useful for large academic medical centers?
No. Because the network is roughly 90% community-based, site and patient identification reaches populations and centers that an academic-only approach would miss.
Built for
Clinical Development
Reduce uncertainty from feasibility through enrollment.
Learn more →CROs and Biobanks
Scale at your fingertips through engaging a singular, diverse network.
Learn more →Related solutions
Signal-Based Action
Real-time oncology signals your team can act on before the window closes.
Learn more →Real-World Data Backed by Guidelines
Real-world insights from integrated clinical data.
Learn more →HCP Education
Reach the physicians already making the decision, inside the workflow.
Learn more →OncoLens Research Network
Connecting cancer care and innovation.
Learn more →Find your next patient or site
Bring your protocol. OncoLens will show you which centers fit it, which patients screen in, and what the analytics say about both.